vs
Side-by-side financial comparison of Solventum (SOLV) and Tapestry, Inc. (TPR). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.9B, roughly 1.0× Tapestry, Inc.). Tapestry, Inc. runs the higher net margin — 17.9% vs 0.6%, a 17.3% gap on every dollar of revenue. On growth, Tapestry, Inc. posted the faster year-over-year revenue change (21.0% vs -3.0%). Over the past eight quarters, Tapestry, Inc.'s revenue compounded faster (9.9% CAGR vs -1.8%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
Tapestry, Inc. is a leading American multinational luxury fashion holding company. It owns three iconic lifestyle brands: Coach, Kate Spade New York, and Stuart Weitzman, offering premium handbags, apparel, footwear, accessories, and fragrances to global consumers via physical retail stores and e-commerce platforms.
SOLV vs TPR — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.9B |
| Net Profit | $13.0M | $343.8M |
| Gross Margin | 54.7% | 76.9% |
| Operating Margin | 4.0% | 22.3% |
| Net Margin | 0.6% | 17.9% |
| Revenue YoY | -3.0% | 21.0% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.07 | $1.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | $1.9B | ||
| Q4 25 | $2.0B | $2.5B | ||
| Q3 25 | $2.1B | $1.7B | ||
| Q2 25 | $2.2B | $1.7B | ||
| Q1 25 | $2.1B | $1.6B | ||
| Q4 24 | $2.1B | $2.2B | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $2.1B | $1.6B |
| Q1 26 | $13.0M | $343.8M | ||
| Q4 25 | $63.0M | $561.3M | ||
| Q3 25 | $1.3B | $274.8M | ||
| Q2 25 | $90.0M | $-517.1M | ||
| Q1 25 | $137.0M | $203.3M | ||
| Q4 24 | $31.0M | $310.4M | ||
| Q3 24 | $122.0M | $186.6M | ||
| Q2 24 | $89.0M | $159.3M |
| Q1 26 | 54.7% | 76.9% | ||
| Q4 25 | 51.4% | 75.5% | ||
| Q3 25 | 54.2% | 76.3% | ||
| Q2 25 | 54.4% | 76.3% | ||
| Q1 25 | 53.8% | 76.1% | ||
| Q4 24 | 53.9% | 74.4% | ||
| Q3 24 | 56.0% | 75.3% | ||
| Q2 24 | 54.6% | 74.9% |
| Q1 26 | 4.0% | 22.3% | ||
| Q4 25 | 6.3% | 28.6% | ||
| Q3 25 | 80.6% | 19.3% | ||
| Q2 25 | 9.9% | -33.9% | ||
| Q1 25 | 7.3% | 16.0% | ||
| Q4 24 | 6.6% | 22.4% | ||
| Q3 24 | 13.2% | 16.7% | ||
| Q2 24 | 11.7% | 14.8% |
| Q1 26 | 0.6% | 17.9% | ||
| Q4 25 | 3.2% | 22.4% | ||
| Q3 25 | 60.4% | 16.1% | ||
| Q2 25 | 4.2% | -30.0% | ||
| Q1 25 | 6.6% | 12.8% | ||
| Q4 24 | 1.5% | 14.1% | ||
| Q3 24 | 5.9% | 12.4% | ||
| Q2 24 | 4.3% | 10.0% |
| Q1 26 | $0.07 | $1.65 | ||
| Q4 25 | $0.37 | $2.68 | ||
| Q3 25 | $7.22 | $1.28 | ||
| Q2 25 | $0.51 | $-2.30 | ||
| Q1 25 | $0.78 | $0.95 | ||
| Q4 24 | $0.18 | $1.38 | ||
| Q3 24 | $0.70 | $0.79 | ||
| Q2 24 | $0.51 | $0.67 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $561.0M | $1.1B |
| Total DebtLower is stronger | $4.6B | $2.4B |
| Stockholders' EquityBook value | $5.0B | $682.4M |
| Total Assets | $14.1B | $6.5B |
| Debt / EquityLower = less leverage | 0.92× | 3.48× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $561.0M | $1.1B | ||
| Q4 25 | $878.0M | $1.1B | ||
| Q3 25 | $1.6B | $743.2M | ||
| Q2 25 | $492.0M | $1.1B | ||
| Q1 25 | $534.0M | $1.1B | ||
| Q4 24 | $762.0M | $1.0B | ||
| Q3 24 | $772.0M | $7.3B | ||
| Q2 24 | $897.0M | $7.2B |
| Q1 26 | $4.6B | $2.4B | ||
| Q4 25 | $5.0B | $2.4B | ||
| Q3 25 | $5.1B | $2.4B | ||
| Q2 25 | $7.8B | $2.4B | ||
| Q1 25 | $7.9B | $2.4B | ||
| Q4 24 | $8.0B | $2.4B | ||
| Q3 24 | $8.1B | $7.0B | ||
| Q2 24 | $8.3B | $6.9B |
| Q1 26 | $5.0B | $682.4M | ||
| Q4 25 | $5.0B | $551.2M | ||
| Q3 25 | $5.0B | $399.5M | ||
| Q2 25 | $3.6B | $857.8M | ||
| Q1 25 | $3.3B | $1.5B | ||
| Q4 24 | $3.0B | $1.3B | ||
| Q3 24 | $3.2B | $3.0B | ||
| Q2 24 | $2.9B | $2.9B |
| Q1 26 | $14.1B | $6.5B | ||
| Q4 25 | $14.3B | $6.5B | ||
| Q3 25 | $14.0B | $6.4B | ||
| Q2 25 | $15.1B | $6.6B | ||
| Q1 25 | $14.5B | $7.3B | ||
| Q4 24 | $14.5B | $7.3B | ||
| Q3 24 | $14.7B | $13.7B | ||
| Q2 24 | $14.6B | $13.4B |
| Q1 26 | 0.92× | 3.48× | ||
| Q4 25 | 1.00× | 4.32× | ||
| Q3 25 | 1.03× | 5.95× | ||
| Q2 25 | 2.14× | 2.77× | ||
| Q1 25 | 2.43× | 1.59× | ||
| Q4 24 | 2.71× | 1.78× | ||
| Q3 24 | 2.54× | 2.35× | ||
| Q2 24 | 2.90× | 2.39× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $-273.0M | — |
| FCF MarginFCF / Revenue | -13.6% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-203.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $95.0M | $1.1B | ||
| Q3 25 | $76.0M | $112.6M | ||
| Q2 25 | $169.0M | $446.8M | ||
| Q1 25 | $29.0M | $144.3M | ||
| Q4 24 | $219.0M | $506.0M | ||
| Q3 24 | $169.0M | $119.5M | ||
| Q2 24 | $355.0M | $256.0M |
| Q1 26 | $-273.0M | — | ||
| Q4 25 | $32.0M | $1.0B | ||
| Q3 25 | $-21.0M | $80.2M | ||
| Q2 25 | $59.0M | $411.5M | ||
| Q1 25 | $-80.0M | $113.4M | ||
| Q4 24 | $92.0M | $475.1M | ||
| Q3 24 | $76.0M | $93.9M | ||
| Q2 24 | $297.0M | $209.8M |
| Q1 26 | -13.6% | — | ||
| Q4 25 | 1.6% | 41.5% | ||
| Q3 25 | -1.0% | 4.7% | ||
| Q2 25 | 2.7% | 23.9% | ||
| Q1 25 | -3.9% | 7.2% | ||
| Q4 24 | 4.4% | 21.6% | ||
| Q3 24 | 3.7% | 6.2% | ||
| Q2 24 | 14.3% | 13.2% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 1.7% | ||
| Q3 25 | 4.6% | 1.9% | ||
| Q2 25 | 5.1% | 2.0% | ||
| Q1 25 | 5.3% | 2.0% | ||
| Q4 24 | 6.1% | 1.4% | ||
| Q3 24 | 4.5% | 1.7% | ||
| Q2 24 | 2.8% | 2.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | 1.93× | ||
| Q3 25 | 0.06× | 0.41× | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 0.21× | 0.71× | ||
| Q4 24 | 7.06× | 1.63× | ||
| Q3 24 | 1.39× | 0.64× | ||
| Q2 24 | 3.99× | 1.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SOLV
| Infection Prevention and Surgical Solutions | $737.0M | 37% |
| Advanced Wound Care | $497.0M | 25% |
| Dental Solutions | $354.0M | 18% |
| Health Information Systems | $342.0M | 17% |
| All Other 4 | $76.0M | 4% |
TPR
Segment breakdown not available.
